Autologus Cell Therapy Market

Autologous Cell Therapy Market (Source - Bone Marrow and Epidermis; Application - Neurology, Orthopedics, Cancer, Wound Healing, CVD, and Autoimmune; End User - Hospitals, Ambulatory Centers, and Research Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • Rep Id : TMRGL715
  • Published On : Jan 2017
  • No. of Pages : 152
  • Category : Healthcare

1. Preface
     1.1. Research Scope
     1.2. Market Segmentation
     1.3. Research Objectives
     1.4. Key Questions Answered

2. Assumptions and Research Methodology
     2.1. Report Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Autologous Cell Therapy Market Snapshot
     3.2. Market Opportunity Map

4. Market Overview
     4.1. Product Overview
     4.2. Key Industry Events
     4.3. Death Rate of Leukemia, by Country
     4.4. Death Rate of Cancer, by Country

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
     5.3. Restraints
     5.4. Opportunities
     5.5. Opportunity Analysis
     5.6. Pipeline Analysis (Phase I & II)

6. Global Autologous Cell Therapy Market Analysis, by Source
     6.1. Key Findings
     6.2. Introduction
     6.3. Bone Marrow
     6.4. Epidermis
     6.5. Others
     6.6. Key Trends
     6.7. Market Attractiveness Analysis

7. Global Autologous Cell Therapy Market Analysis, by Application
     7.1. Key Findings
     7.2. Introduction
     7.3. Neurology
     7.4. Orthopedic
     7.5. Cancer
     7.6. Wound Healing
     7.7. CVD
     7.8. Autoimmune
     7.9. Others
     7.10. Key Trends
     7.11. Market Attractiveness Analysis

8. Global Autologous Cell Therapy Market Analysis, by End-user
     8.1. Key Findings
     8.2. Introduction
     8.3. Hospitals
     8.4. Ambulatory Centers     
     8.5. Research Centers
     8.6. Key Trend Analysis
     8.7. Market Attractiveness Analysis

9. Global Autologous Cell Therapy Market Analysis, by Region
     9.1. North America
     9.2. Europe
     9.3. Asia Pacific
     9.4. Latin America
     9.5. Middle East & Africa
     9.6. Market Attractiveness Analysis

10. North America Autologous Cell Therapy Market Analysis
     10.1. North America Autologous Cell Therapy Market Size Forecast, By Country, 2016-2024
     10.2. North America Market Size Forecast, By Source, 2016-2024
     10.3. North America Market Size Forecast, By Application, 2016-2024
     10.4. North America Market Size Forecast, By End-user, 2016-2024
     10.5. North America Market Attractiveness Analysis, 2016-2024

11. Europe Autologous Cell Therapy Market Analysis
     11.1. Europe Market Size Forecast, By Country, 2016-2024
     11.2. Europe Market Size Forecast, By Source, 2016-2024
     11.3. Europe Market Size Forecast, By Application, 2016-2024
     11.4. Europe Market Size Forecast, By End-user, 2016-2024
     11.5. Europe Market Attractiveness Analysis, 2016-2024

12. Asia Pacific Autologous Cell Therapy Market Analysis
     12.1. Asia Pacific Market Size Forecast, By Country, 2016-2024
     12.2. Asia Pacific Market Size Forecast, By Source, 2016-2024
     12.3. Asia Pacific Market Size Forecast, By Application, 2016-2024
     12.4. Asia Pacific Market Size Forecast, By End-user, 2016-2024
     12.5. Asia Pacific Market Attractiveness Analysis, 2016-2024

13. Latin America Autologous Cell Therapy Market Analysis
     13.1. Latin America Market Size Forecast, By Country, 2016-2024
     13.2. Latin America Market Size Forecast, By Source, 2016-2024     
     13.3. Latin America Market Size Forecast, By Application, 2016-2024
     13.4. Latin America Market Size Forecast, By End-user, 2016-2024
     13.5. Latin America Market Attractiveness Analysis, 2016-2024

14. Middle East & Africa Autologous Cell Therapy Market Analysis
     14.1. Middle East & Africa Market Size Forecast, By Country, 2016-2024
     14.2. Middle East & Africa Market Size Forecast, By Source, 2016-2024
     14.3. Middle East & AfricaMarket Size Forecast, By Application, 2016-2024
     14.4. Middle East & Africa Market Size Forecast, By End-user, 2016-2024
     14.5. Middle East & Africa Market Attractiveness Analysis, 2016-2024

15. Competitive Landscape
     15.1. Competition Matrix
     15.1. Pharmicell Co., Inc.
     15.2. Fibrocell Science, Inc. 
     15.3. Vericel Corporation
     15.4. BioTime, Inc.

16. Company Profiles
     16.1. BioTime, Inc.
             16.1.1. Company Details
             16.1.2. Company Description
             16.1.3. Business Overview
             16.1.4. SWOT Analysis
             16.1.5. Financial Analysis
             16.1.6. Strategic Overview
     16.2. BrainStorm Cell Therapeutics
             16.2.1. Company Details
             16.2.2. Company Description
             16.2.3. Business Overview
             16.2.4. SWOT Analysis
             16.2.5. Financial Analysis
             16.2.6. Strategic Overview
     16.3. Caladrius Biosciences, Inc.
             16.3.1. Company Details
             16.3.2. Company Description
             16.3.3. Business Overview
             16.3.4. SWOT Analysis
             16.3.5. Financial Analysis
             16.3.6. Strategic Overview
     16.4. Fibrocell Science, Inc.
             16.4.1. Company Details
             16.4.2. Company Description
             16.4.3. Business Overview
             16.4.4. SWOT Analysis
             16.4.5. Financial Analysis
             16.4.6. Strategic Overview
     16.5. Opexa Therapeutics, Inc.
             16.5.1. Company Details
             16.5.2. Company Description
             16.5.3. Business Overview
             16.5.4. SWOT Analysis
             16.5.5. Financial Analysis
             16.5.6. Strategic Overview
     16.6. Pharmicell Co., Inc.
             16.6.1. Company Details
             16.6.2. Company Description
             16.6.3. Business Overview
             16.6.4. SWOT Analysis
             16.6.5. Financial Analysis
             16.6.6. Strategic Overview
     16.7. Regeneus Ltd.
             16.7.1. Company Details
             16.7.2. Company Description
             16.7.3. Business Overview
             16.7.4. SWOT Analysis
             16.7.5. Financial Analysis
             16.7.6. Strategic Overview
     16.8. TiGenix NV
             16.8.1. Company Details
             16.8.2. Company Description
             16.8.3. Business Overview
             16.8.4. SWOT Analysis
             16.8.5. Financial Analysis
             16.8.6. Strategic Overview
     16.9. TxCell SA
             16.9.1. Company Details
             16.9.2. Company Description
             16.9.3. Business Overview
             16.9.4. SWOT Analysis
             16.9.5. Financial Analysis
             16.9.6. Strategic Overview
     16.10. U.S. Stem Cell, Inc.
             16.10.1. Company Details
             16.10.2. Company Description
             16.10.3. Business Overview
             16.10.4. SWOT Analysis
             16.10.5. Financial Analysis
             16.10.6. Strategic Overview
     16.11. Vericel Corporation
             16.11.1. Company Details
             16.11.2. Company Description
             16.11.3. Business Overview
             16.11.4. SWOT Analysis
             16.11.5. Financial Analysis
             16.11.6. Strategic Overview

List of Tables

TABLE 1 Global Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 2 Global Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 3 Global Market Size (US$ Mn) & Forecast, by End-user, 2016–2024
TABLE 4 Global Market Size (US$ Mn) Forecast, by Region, 2016–2024
TABLE 5 North America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 6 North America Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 7 North America Market Size (US$) Forecast, by Application, 2016–2024
TABLE 8 North America Market Size (US$ Mn) Forecast, by End-user, 2016–2024
TABLE 9 Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 10 Europe Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 11 Europe Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 12 Europe Market Size (US$ Mn) Forecast, by End-user, 2016–2024
TABLE 13 Asia Pacific Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 14 Asia Pacific  Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 15 Asia Pacific Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 16 Asia Pacific Market Size (US$ Mn) Forecast, by End-user, 2016–2024
TABLE 17 Latin America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 18 Latin America Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 19 Latin America Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 20 Latin America Market Size (US$ Mn) Forecast, by End-user, 2016–2024
TABLE 21 MEA Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 22 MEA Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 23 MEA Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 24 MEA Market Size (US$ Mn) Forecast, by End-user, 2016–2024

List of Figures

FIG. 1 Global Autologous Cell Therapy Market Value Share Analysis, by Source, 2015 and 2024
FIG. 2 Global Bone Marrow Market Size Forecast (US$ Mn), 2016–2024
FIG. 3 Global Epidermis Market Size Forecast (US$ Mn), 2016–2024
FIG. 4 Global Others Market Size Forecast (US$ Mn), 2016–2024
FIG. 5 Autologous Cell Therapy Market Attractiveness Analysis, by Source
FIG. 6 Global Autologous Cell Therapy Market Value Share Analysis, by Application, 2015 and 202
FIG. 7 Global Bone Marrow Market Size Forecast (US$ Mn), 2016–2024
FIG. 8 Global Epidermis Market Size Forecast (US$ Mn), 2016–2024
FIG. 9 Global Bone Marrow Market Size Forecast (US$ Mn), 2016–2024
FIG. 10 Global Epidermis Market Size Forecast (US$ Mn), 2016–2024
FIG. 11 Global Bone Marrow Market Size Forecast (US$ Mn), 2016–2024
FIG. 12 Global Epidermis Market Size Forecast (US$ Mn), 2016–2024
FIG. 13 Global Others Market Size Forecast (US$ Mn), 2016–2024
FIG. 14 Global Autologous Cell Therapy Market Attractiveness Analysis, by Application
FIG. 15 Global Market Value Share Analysis, by End-user, 2015 and 2024
FIG. 16 Global Hospitals Market Size Forecast (US$ Mn), 2016–2024
FIG. 17 Global Ambulatory Centers Market Size Forecast (US$ Mn), 2016–2024
FIG. 18 Global Research Centers Market Revenue (US$ Mn), 2014–2024
FIG. 19 Global Autologous Cell Therapy Market Attractiveness Analysis, by End-user
FIG. 20 North America Market Size (US$ Mn) Forecast, 2016–2024
FIG. 21 Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 22 Asia Pacific Market Size (US$ Mn) Forecast, 2016–2024
FIG. 23 Latin America Market Size (US$ Mn) Forecast, 2016–2024
FIG. 24 MEA Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 25 Global Autologous Cell Therapy Market Attractiveness Analysis, by Region
FIG. 26 U.S. Market Size (US$ Mn) Forecast, 2016–2024
FIG. 27 Canada Market Size (US$ Mn) Forecast, 2016–2024
FIG. 28 North America Autologous Cell Therapy Market Attractiveness Analysis, by Country
FIG. 29 North America Market Attractiveness Analysis, by Source
FIG. 30 North America Market Attractiveness Analysis, by Applicat
FIG. 31 North America Market Attractiveness Analysis, by End-user
FIG. 32 Germany Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 33 U.K. Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 34 France Market Size (US$ Mn) Forecast, 2016–20
FIG. 35 Spain Market Size (US$ Mn) Forecast, 2016–2024
FIG. 36 Switzerland Market Size (US$ Mn) Forecast, 2016–2024
FIG. 37 Rest of Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 38 Europe Autologous Cell Therapy Market Attractiveness Analysis, by Country
FIG. 39 Europe Market Attractiveness Analysis, Source
FIG. 40 Europe Market Attractiveness Analysis, by Applicatio
FIG. 41 Europe Market Attractiveness Analysis, by End-user
FIG. 42 Japan Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 43 China Market Size (US$ Mn) Forecast, 2016
FIG. 44 India Market Size (US$ Mn) Forecast, 2016–2024
FIG. 45 Rest of APAC Autologous Cell Therapy Market Size (US$ Mn) Forecast, 
FIG. 46 2016–2024
FIG. 47 Asia Pacific Market Attractiveness Analysis, by Country
FIG. 48 Asia Pacific  Market Attractiveness Analysis, by Source
FIG. 49 Asia Pacific Market Attractiveness Analysis, by Application
FIG. 50 Asia Pacific Market Attractiveness Analysis, by End-user
FIG. 51 Brazil Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–202
FIG. 52 Mexico Market Size (US$ Mn) Forecast, 2016–2024
FIG. 53 Rest of LATAM Market Size (US$ Mn) Forecast, 2016–2024
FIG. 54 Latin America Autologous Cell Therapy Market Attractiveness Analysis, by Country
FIG. 55 Latin America Market Attractiveness Analysis, by Source
FIG. 56 Latin America Market Attractiveness Analysis, by Application
FIG. 57 Latin America Market Attractiveness Analysis, by End-user
FIG. 58 South Africa Market Size (US$ Mn) Forecast, 2016–2024
FIG. 59 Saudi Arabia Market Size (US$ Mn) Forecast, 2016–2024
FIG. 60 Rest of MEA Market Size (US$ Mn) Forecast, 2016–2024
FIG. 61 Middle East & Africa Market Attractiveness Analysis, by Country
FIG. 62 Middle East & Africa Market Attractiveness Analysis, by Source
FIG. 63 Middle East & Africa Market Attractiveness Analysis, by Application

.